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Background: This study compared changes in measured versus predicted
peak aerobic power (V̇O2peak) following cardiovascular rehabilitation (CR). Peak
cardiopulmonary exercise testing (CPET) results were compared to four V̇O2peak
estimation methods: the submaximal modified Bruce treadmill, Astrand-Ryhming cycle
ergometer, and Chester step tests, and the Duke Activity Status Index (DASI).
Methods: Adults with cardiovascular disease (CVD) who completed a 12-week CR
program were assessed at baseline and 12 weeks follow-up. CPET, the DASI and three
subsequent submaximal exercise tests were performed in a random order.
Results: Of the 50 adults (age: 57 ± 11 years) who participated, 46 completed
the 12-week CR program and exercise tests. At baseline 69, 68, and 38% of the
treadmill, step and cycle tests were successfully completed, respectively. At follow-up
67, 80, and 46% of the treadmill, step and cycle tests were successfully completed,
respectively. No severe adverse events occurred. Significant improvements in V̇O2peak
were observed with CPET (3.6 ± 5.5 mL.kg−1.min−1, p < 0.001) and the DASI
(2.3 ± 4.2 mL.kg−1.min−1, p < 0.001). Bland-Altman plots of the change in V̇O2peak
between CPET and the four V̇O2peak estimation methods revealed the following: a
proportional bias and heteroscedastic 95% limits of agreement (95% LoA) for the
treadmill test, and for the cycle and step tests and DASI, mean bias’ and 95%
LoA of 1.0 mL.kg−1.min−1 (21.3, −19.3), 1.4 mL.kg−1.min−1 (15.0, −12.3) and
1.0 mL.kg−1.min−1 (13.8, −11.8), respectively.
Conclusion: Given the greater number of successful tests, no serious adverse events
and acceptable mean bias, the step test appears to be a valid and safe method for
assessing group-level mean changes in V̇O2peak among patients in CR. The DASI also
appears to be a valid and practical questionnaire. Wide limits of agreement, however,
limit their use to predict individual-level changes.
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INTRODUCTION
Cardiovascular rehabilitation (CR) programs have been
consistently shown to improve patients’ peak aerobic power
(V̇O2peak), which independently predicts lower all-cause and
cardiovascular disease-specific mortality (Keteyian et al., 2008;
Kodama et al., 2009). A one metabolic equivalent increase in
V̇O2peak (1-MET = V̇O2 of 3.5 mL.kg−1.min−1) is associated
with an approximate 17% and 15% decrease in all-cause and
cardiovascular disease-specific mortality in men and women
with coronary heart disease, respectively (Keteyian et al.,
2008). The assessment of V̇O2peak, as measured by symptom-
limited cardiopulmonary exercise testing with ergospirometry
(CPET), remains the “gold-standard” for assessing patients’
cardiopulmonary responses to CR (Canadian Association of
Cardiac Rehabilitation, 2009); it is also used for risk stratification
and the development of safe and effective exercise programs
(Canadian Association of Cardiac Rehabilitation, 2009). CPET
is, however, often impractical or impossible due to the costs,
time, expertise and technological resources required (Grace et al.,
2016). There remains a need to assess peak aerobic power using
simple, straightforward and easily-performed evaluations in all
settings. Consequently, a number of submaximal exercise tests
[terminated at intensities at or below 85% of peak heart rate
(HR)] and questionnaires have been developed to reduce testing
costs, time, resources, and risks (Hlatky et al., 1989; Noonan and
Dean, 2000; Arena et al., 2007).
Systematic reviews (Evans et al., 2015; Bennett et al., 2016)
and recent original studies (Hughes and Chaturvedi, 2017;
Kokkinos et al., 2017, 2018; Guo et al., 2018) have shown
that submaximal exercise tests (e.g., treadmill, cycle, step, and
squat tests) to predict V̇O2peak in apparently healthy adults
are moderately to highly accurate. Submaximal exercise testing
is widely used in the United Kingdom (Cowie et al., 2019)
and increasingly promoted in low-resource settings (Grace
et al., 2016). These tests are not routinely performed within
most CR programs in North America, yet may provide an
alternative valid, safe and highly practical approach to assessing
changes in V̇O2peak.
Several investigators have examined the validity of
submaximal exercise tests (e.g., modified Bruce treadmill
test, “warm-up” cycling, and body motion during 45-s of
squatting) in predicting V̇O2peak when compared to CPET at a
single time point in patients with coronary heart disease (Milani
et al., 1996, 1998; Hautala et al., 2013; Papini et al., 2017), and
the safety and practicality of exercise tolerance testing in CR
(Simms et al., 2007). Others have also explored the validity of
questionnaires in predicting V̇O2peak when compared to CPET
in patients with heart disease (Rankin et al., 1996; Shaw et al.,
2006). Yet, no studies have assessed changes in V̇O2peak following
CR as predicted by submaximal exercise tests and a self-reported
activity status questionnaire when compared to CPET in patients
with cardiovascular disease (CVD).
The purpose of this study was to assess changes in V̇O2peak
following CR as predicted by three submaximal exercise tests
(treadmill, cycle and step tests) and a self-reported activity status
questionnaire, which were validated by comparison with CPET
in patients with CVD. A secondary purpose was to examine the
safety of these submaximal exercise tests. We hypothesized that
submaximal exercise tests would provide a valid and safe estimate




This was a single-center pre-post experimental study (see
Figure 1) conducted at the University of Ottawa Heart Institute
(UOHI), a tertiary-care cardiovascular health center. This study
has been described in accordance with the Strengthening the
Reporting of Observational Studies in Epidemiology (STROBE)
guidelines (von Elm et al., 2007). The study received ethics
approval from the Ottawa Health Sciences Network Research
Ethics Board (Protocol #: 20150443-01H). This study was
conducted in line with the Declaration of Helsinki.
Participants
Patients eligible for our CR program included those who have
heart failure or experienced a myocardial infarction, heart
surgery (e.g., coronary artery bypass graft, valve replacement
or repair), heart transplantation, angioplasty and or pacemaker
or defibrillator implant. Physiotherapists and nurses involved
with our on-site CR program who were blinded to the
study purposes referred patients who: (1) were enrolled in
moderate to high functional capacity exercise classes [i.e.,
those who planned to exercise at ≥5 metabolic equivalents
(METs)], and (2) consented to being contacted for research
studies. Eligible participants were: (1) enrolled in an on-site
CR program at the UOHI; (2) able to complete a symptom-
limited CPET; and, (3) able and willing to provide written
informed consent. Potential participants were excluded if they:
(1) were unable to read and understand English or French;
(2) were scheduled for a 6-min walk test (6MWT) per the
established UOHI CR program algorithm (i.e., patients with
very low exercise tolerance receive 6MWTs to assess their
functional capacity pre-post CR); (3) were unable to complete
submaximal exercise testing (i.e., treadmill, bicycle, and step) due
to musculoskeletal limitations; or, (4) were currently pregnant
or planning to become pregnant during the study period.
All participants were recruited between November 2015 and
December 2016, and provided written informed consent prior
to participation.
Exercise Testing
Participants were asked to adhere to the following instructions
prior to their peak and submaximal exercise tests: (1) to take their
usual medications, especially anti-arrhythmics (e.g., β-blockers)
at least 1 h before testing; (2) avoid caffeine consumption at
least 2 h before testing; (3) to refrain, if possible, from cigarette
smoking at least 1 h before testing; (4) to void their bladder
at least 30 min before testing; (5) if a diabetic patient, to have
eaten or ensure adequate blood glucose levels (as per UOHI CR
program policies) prior to testing; and, (6) to reschedule tests
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FIGURE 1 | Schematic of study flow. CPET, cardiopulmonary exercise testing; R, random order.
if participants felt unwell due to respiratory, gastrointestinal or
febrile illness within 48 h of their appointments.
Measured Peak Aerobic Power
V̇O2peak was measured using a symptom-limited CPET with
ergospirometry on a treadmill using a ramp protocol at the
beginning and conclusion of a 12-week CR program by cardiac
stress technologists in the Department of Cardiac Imaging at
the UOHI. This ramp protocol involves walking or jogging
at a constant speed (e.g., 2.0, 3.0, or 4.0 mph) dependant on
participants’ functional abilities with a 1.7% increase in grade
every minute until volitional fatigue is achieved (Myers et al.,
1992; American College of Sports Medicine, 2017). Gas exchange
(V̇O2 and V̇CO2) was monitored continuously using a metabolic
cart (Sensormedics Vmax, Yorba Linda, CA, United States), and
HR was measured using ECG. The highest 10-s interval averages
of V̇O2 and HR were considered the peak V̇O2 and HR values.
Peak HR values were used for submaximal treadmill and step
exercise test termination criteria (i.e., 85% peak HR).
Estimated Peak Aerobic Power;
Submaximal Exercise Tests
Three submaximal exercise tests (Modified Bruce treadmill,
Astrand-Rhyming cycle ergometer and Chester step) were
performed in a random order [using the “RAND” function of
a software spreadsheet program (Excel, Microsoft, Washington,
United States) within 2 weeks of the CPETs and before the
participants’ first three and last three consecutive CR classes
(i.e., held on separate days)]. These classes were held at the
same time each week for each participant (e.g., 10:00 h Tuesdays
and Thursdays). Approximately 15 min of rest was provided
before each submaximal exercise test, which was conducted
by an exercise specialist (i.e., Registered Kinesiologist, Certified
Exercise Physiologist, or Physiotherapist) in accordance with
the American College of Sports Medicine (ACSM) guidelines
(American College of Sports Medicine, 2017). During all
submaximal exercise tests, heart rate and perceived exertion were
measured by Polar HR monitors (FT1, Polar Electro, Kempele,
Finland) and the Borg Rating of Perceived Exertion (RPE) scale
(6–20 points). RPE values were calibrated for each participant
before each test, by ensuring each participant began the tests at
“no exertion at all” (point 6).
Modified Bruce Treadmill Test
Participants walked on a motorized treadmill (Precor C954i,
Woodinville, Washington, United States) for 3-min stages
of increasing speeds and grades (Stage 1: speed = 1.7 mph,
grade = 0%; Stage 2: speed = 1.7 mph, grade = 5%; Stage 3:
speed = 1.7 mph, grade = 10%; Stage 4: speed = 2.5 mph,
grade = 12%; Stage 5: speed = 3.4 mph, grade = 14%; Stage 6:
speed = 4.2 mph, grade = 15%; and Stage 7: speed = 5.0 mph,
grade = 15%). Exercise HRs and RPEs were collected at the end
of each 3-min stage. Tests were terminated: at the end of the stage
during which participants reached 85% of their peak HR; when
the participant requested to stop; or, the exercise specialist felt the
participants could not safely continue. The speed and grade of the
last completed stage were used to estimate V̇O2 from the ACSM
walking equation (V̇O2peak = [speed (m/min) × 0.1] + [grade
(decimal) × speed (m/min) × 1.8] + 3.5) (American College
of Sports Medicine, 2017). The following equations were
then used to extrapolate V̇O2peak: (1) Slope (β) = (V̇O2
last stage – V̇O2 second last stage)/(HR last stage – HR
second last stage); and, (2) V̇O2peak = V̇O2 last stage + β
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(HRpeak – HR last stage) (Heyward, 2010). Successful
tests were defined as a participant completing at least
two stages (to extrapolate V̇O2peak) and reaching 85% of
HRpeak upon completion of the final stage (Heyward, 2010;
American College of Sports Medicine, 2017).
Astrand-Ryhming Cycle Ergometer Test
Participants cycled on an upright cycle ergometer (True Fitness,
CS200, St. Louis, MO, United States at 50, 75, 100, 125, or
150 watts (or as close as possible to one of these wattages
given a participant’s physical capabilities) while maintaining
a pedal rate of 50 ± 5 rpm for the duration of the
6 min test. Exercise HR and RPE were collected at the end
of minutes 5 and 6. The average of these HRs and the
final watts were used to predict V̇O2peak from a nomogram
(American College of Sports Medicine, 2017). An age correction
factor was applied to this value (American College of Sports
Medicine, 2017). Astrand et al. reported a correlation (r) of
0.78 between measured V̇O2peak from CPET and predicted
V̇O2peak from the Astrand-Ryhming cycle ergometer test using
the age-correction factor (Astrand, 1960). Successful tests were
defined as a participant having completed the 6-min test at
a workload to produce exercise HRs within the range of
120–170 bpm (the HR range required to predict V̇O2peak
from the nomogram).
Chester Step Test
Using a step height (i.e., 15, 20, 25, or 30 cm) suitable
to a participant’s functional level, participants stepped to a
metronome beat of 15 steps per minute for 2 min following
which HR and RPE were recorded. The step rate then increased
to 20 steps per minute for 2 min following which HR and
RPE were recorded. The test continued in this progressive
manner to a maximum of five stages, until the end of the
stage during which participants reached 85% of their peak
HR (American College of Sports Medicine, 2017). The end of
stage HRs, end of stage V̇O2 values from the Chester Step
Test data sheet, and measured peak HRs from CPETs were
entered into a spreadsheet program (Microsoft Excel, Microsoft
Canada Inc., Mississauga, ON, Canada) to extrapolate V̇O2peak
using the “trendline” function. Successful tests were defined as a
participant having completed at least two stages (to extrapolate
V̇O2peak) and reaching 85% of HRpeak upon completion of
the final stage.
Duke Activity Status Index
Participants completed the Duke Activity Status Index (DASI),
a 12-item questionnaire that assesses daily activities such as
personal care, ambulation, household tasks, sexual function
and recreation activities at the beginning and following the
12-week CR program. Each activity is associated with an
activity-specific value. Participants were asked to identify each
activity they were able to perform. The values were summed
and entered into the following equation to estimate peak
exercise capacity: V̇O2peak = (0.43 × DASI value) + 9.6
(Hlatky et al., 1989).
Cardiovascular Rehabilitation
The CR program included: a CVD risk-factor modification
consultation with a physiotherapist or registered nurse;
medical assessment if deemed appropriate; referral to services
which support CVD risk-factor management (i.e., vocational
counseling, nutritional counseling, stress-management,
social work and/or psychological support, if required); and,
supervised exercise training sessions twice weekly in the
Cardiac Prevention and Rehabilitation Center for 12 weeks.
Risk-factor management addressed the importance of regular
physical activity, healthy eating, smoking cessation, and stress
management. Each exercise training session was 45–60 min
in duration and included: (i) warm-up for 5–10 min; (ii)
conditioning for 20–40 min at 40–85% HRR (RPE: 12–16);
and, (iii) cool-down for 5–10 min (Canadian Association of
Cardiac Rehabilitation, 2009). Resting (obtained following a
5 min rest period) and peak HRs obtained from the baseline
CPETs were used to compute % heart rate reserve (HRR)
(% HRR = [(HRpeak – HRrest × % intensity) + HRrest]
(American College of Sports Medicine, 2017).
Outcome Measures
Demographics and Medical Conditions
Demographics were retrieved from patients’ medical records
and included age, sex, ethnicity, cardiovascular history and
medication use.
Anthropometrics and Hemodynamics
Height was measured to the nearest 0.5 cm; body mass was
measured to the nearest 0.1 kg at the beginning and completion
of CR, and body mass index (BMI) was subsequently calculated
(kg/m2). Waist circumference was measured to the nearest
0.5 cm at the midpoint between the lower costal margin and
iliac crest while participants stood with arms at their sides,
feet 25–30 cm apart and abdomen relaxed before and after
completion of CR. Resting blood pressure and HR were measured
using an automated, non-invasive blood pressure monitor (Bp-
TRU, Canada; or, Welch Allyn, Canada) by CR professionals at
baseline and following 12 weeks. All measures were performed in
triplicate, and the averages reported.
Statistical Analysis
We used PASS to calculate the required sample size (Pass
13, NCSS, Utah, United States). Using a moderate correlation
coefficient of 0.5, an alpha of 0.05 and adequate power (1-β) of
0.80, a sample size of 46 participants was required to assess the
association of changes (from baseline to follow-up) in V̇O2peak
following CR as predicted by three submaximal exercise tests
and a self-reported activity status questionnaire with changes
in V̇O2peak measured by CPET. We adjusted our sample size
upward (N = 50) to account for a planned 10% loss to follow-up.
Analyses were performed using SPSS for Windows (version
24; IBM Corp., Armonk, NY, United States). All outcome
variables were tested for normality using Shapiro–Wilk tests;
baseline and follow-up V̇O2peak as predicted by the treadmill
tests and DASI were not normally distributed. Descriptive
analyses of the participants’ demographics and anthropometrics,
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cardiovascular conditions, medications and exercise test
characteristics were performed. Paired t-tests and Wilcoxon
signed–rank tests were used to examine changes in measured and
predicted V̇O2peak for normally and non-normally distributed
variables, respectively.
Pearson’s product-moment correlations were used to examine
the association between measured and predicted V̇O2peak
values obtained from CPET, submaximal exercise tests and
the DASI. Linear regression analyses were used to examine
whether proportional bias existed between measured and
predicted V̇O2peak values. When there was no proportional
bias (i.e., homoscedastic scatter), paired t-tests were used to
examine whether systematic error existed between measured and
predicted VO2peak values within participants at baseline and for
changes. Bland-Altman plots were used for visual presentation of
the agreement between CPET and submaximal exercise test and
DASI V̇O2peak values (Bland and Altman, 1986; Ludbrook, 2010).
If proportional bias was detected, a line of best fit was presented;
this method is recommended when the mean and standard
deviation of the differences are not constant (Bland and Altman,
1999; Ludbrook, 2010). Data are reported as mean ± standard
deviation, and p < 0.05 was considered statistically significant.
RESULTS
Participant Study Flow
A total of 74 participants were referred to the study coordinator.
Fifty participants met the eligibility criteria and consented
to participate; the remaining 24 candidates declined for the
following reasons: lack of time (n = 6); illness or worsening of
symptoms (n = 5); did not want to delay starting CR to complete
baseline study measures (n = 4); lack of interest (n = 4); fearful
of CPET (n = 2); no longer enrolled in CR (n = 1); not available
for study appointments (n = 1); or, had pacemaker which limited
exercise HRs (n = 1). Forty-six of the 50 participants completed
the 12-week CR program and follow-up measures; this represents
an 8% loss to follow-up.
Participant Characteristics
Descriptive data for participants are shown in Table 1.
The participants were predominately male, Caucasian and
overweight, had poor to good exercise tolerance (American
College of Sports Medicine, 2017) and multiple cardiovascular
conditions. Most participants were taking anti-platelet, statin,
β-blocker and ACE inhibitor medications. On average,
participants exercised at between 72 and 82% of their HRR
throughout the 12-week CR program.
Characteristics and Success of Baseline
and Follow-Up CPET
At baseline, participants achieved an average peak HR and
respiratory exchange ratio (RER) of 141.5 ± 22.9 bpm
and 1.1 ± 0.1, respectively, during their CPET. At follow-
up, participants achieved an average peak HR and RER of
146.2 ± 20.3 bpm and 1.1 ± 0.1, respectively, during their
TABLE 1 | Participant characteristics.
Mean ± SD
Demographics and Anthropometrics (n = 47)
Age (years) 57 ± 11
Sex (% male) 77
Ethnicity (% white) 85
Height (cm) 171.0 ± 9.6
Body mass (kg) 83.8 ± 16.0
BMI (kg/m2) 28.7 ± 5.2
Waist circumference (cm) 100.2 ± 12.7
Resting systolic blood pressure (mmHg) 120 ± 14
Resting diastolic blood pressure (mmHg) 73 ± 9
Resting heart rate (bpm) 68 ± 12
Cardiovascular conditions (n = 47)
Percutaneous coronary intervention, yes: no, n 30:17
STEMI, yes: no, n 15:32
Angiogram, yes: no, n 11:36
Non-STEMI, yes: no, n 8:39
Coronary artery bypass grafting surgery, yes: no, n 7:40
Angina, yes: no, n 6:41
Atrial fibrillation, yes: no, n 5:42
Previous myocardial infarction, yes: no, n 2:45
Mitral value surgery, yes: no, n 2:45
Aortic valve surgery, yes: no, n 1:46
Acute coronary syndrome, yes: no, n 1:46
Ablation, yes: no, n 1:46
Medications (n = 49)
Anti-platelet, yes: no, n 48:1
Statins, yes: no, n 41:8
β-blocker, yes: no, n 33:16
ACE inhibitor, yes: no, n 20:29
Nitroglycerin, yes: no, n 18:31
Angiotensin II receptor antagonist, yes: no, n 3:46
Calcium channel blocker, yes: no, n 3:46
Thiazide diuretic, yes: no, n 3:46
PCSK9 inhibitor, yes: no, n 1:48
ACE, angiotensin-converting enzyme; BMI, body mass index; ICD, implantable
cardioverter-defibrillator; PCSK, proprotein convertase subtilisin/kexin; SD,
standard deviation; STEMI, ST-elevation myocardial infarction.
CPET. All CPETs were deemed successful, as these were peak
tests which participants terminated when volitional fatigue
was achieved. The number and percentage of successful
treadmill, step and cycle tests as well as the number and
percentage of participants who completed incremental
treadmill and step test stages are shown in Table 2. Not all
the same participants were successful or unsuccessful for
different tests.
Modified Bruce Treadmill Tests
Baseline
The baseline V̇O2peak values demonstrated by the submaximal
treadmill tests are shown in Table 3. Significant positive
correlations between the V̇O2peak values measured by
CPET and those predicted by the treadmill tests were
observed (r = 0.656, p < 0.001). A significant proportional
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TABLE 2 | The number and percentage of successful treadmill, step and cycle
tests as well as participants who completed incremental treadmill and step test
stages.
Baseline Follow-up
Treadmill, n (%) successful 34 (69%) 31 (67%)
Stage of termination, n (%)
Stage 2 4 (12%) 2 (7%)
Stage 3 6 (18%) 5 (16%)
Stage 4 18 (53%) 13 (42%)
Stage 5 5 (15%) 10 (32%)
Stage 6 1 (3%) 0 (0%)
Stage 7 0 (0%) 1 (3%)
Step, n (%) successful 34 (68%) 37 (80%)
Stage of termination, n (%)
Stage 2 4 (12%) 3 (8%)
Stage 3 15 (44) 10 (27%)
Stage 4 13 (38) 18 (49%)
Stage 5 2 (6) 6 (16%)
Cycle, n (%) successful 19 (38%) 21 (46%)
Stages 2 to 7 only are reported because successful tests were defined as the
participant completing at least two stages.
bias and an apparent heteroscedastic limits of agreement
between the V̇O2peak values measured by CPET and those
predicted by the treadmill tests were observed (F = 11.029,
p = 0.002, n = 34).
Follow-Up
The follow-up and changes in V̇O2peak values demonstrated
by the submaximal treadmill tests are shown in Table 3.
No significant correlations between the change in V̇O2peak
values measured by CPET and those predicted by the
treadmill tests were observed (r = 0.202, p = 0.356).
A significant proportional bias between the change in
V̇O2peak values measured by CPET and those predicted by
the treadmill tests was observed (F = 27.382, p < 0.001,
n = 23). Proportional bias remained with the removal of
an outlier (i.e., a −49 mL.kg−1.min−1 difference in the
change in V̇O2peak measured by CPET and that predicted
by the treadmill test). Bland-Altman plots showing the level
of agreement between measured and predicted changes
in the V̇O2peak values are shown in Figure 2. A total
of 22% of differences in changes in V̇O2peak values fell
within ± 1.75 mL.kg−1.min−1 (0.5 METs) of the mean
bias for the treadmill tests.
Astrand-Ryhming Cycle Ergometer Tests
Baseline
The baseline V̇O2peak values demonstrated by the submaximal
cycle tests are shown in Table 3. No significant correlations
between the V̇O2peak values measured by CPET and those
predicted by the cycle tests were observed (r =−0.003, p = 0.991).
No significant differences between the V̇O2peak values predicted
by the cycle tests and those measured by CPET were observed
(31.3± 7.0 vs. 27.5± 5.3 mL.kg−1.min−1, p = 0.077, n = 19); the
mean bias and 95% limits of agreement was 3.8 mL.kg−1.min−1
(21.0,−13.4).
Follow-Up
The follow-up and changes in V̇O2peak values demonstrated
by the submaximal cycle tests are shown in Table 3. No
significant correlations between the change in V̇O2peak values
measured by CPET and those predicted by the cycle tests were
observed (r = −0.313, p = 0.322). No significant differences in
the change in V̇O2peak values measured by CPET and those
predicted by the cycle tests were observed (13.5 ± 7.1 vs.
TABLE 3 | Baseline, follow-up and change in V̇O2peak, and analyses testing for proportional bias and associations between changes in V̇O2peak values measured by
CPET and those predicted by estimation methods.
Baseline
Mean ± SD n
Follow-up
Mean ± SD n
Change
Mean ± SD n
Linear regression (to
test for proportional














CPET (mL.kg−1.min−1) 25.9 ± 6.3 30.0 ± 6.7 3.6 ± 5.5∗ – –
n = 50 n = 46 n = 46
Modified Bruce Treadmill Test
(mL.kg−1.min−1)
29.3 ± 9.2 32.4 ± 13.9 3.5 ± 12.5 F = 27.382, p < 0.001 r = 0.202, p = 0.356




31.3 ± 7.0 32.5 ± 6.4 2.5 ± 5.7 F = 0.521, p = 0.487 r = −0.313, p = 0.322
n = 19 n = 21 n = 12
Chester Step Test
(mL.kg−1.min−1)
30.4 ± 5.6 32.4 ± 6.3 1.9 ± 5.0 F = 0.188, p = 0.668 r = 0.127, p = 0.513
n = 34 n = 37 n = 29
Duke Activity Status Index
(mL.kg−1.min−1)
29.5 ± 5.2 32.2 ± 4.1 2.3 ± 4.2∗ F = 2.562, p = 0.117 r = 0.085, p = 0.587
n = 48 n = 45 n = 43
CPET, cardiopulmonary exercise test; SD, standard deviation. ∗, denotes significant change from baseline to follow-up.
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FIGURE 2 | Bland-Altman plots comparing measured and predicted changes in V̇O2peak for (A) Bruce treadmill, (B) Astrand-Ryhming cycle ergometer, and (C)
Chester step tests, and (D) DASI. The red line represents mean differences between measured and predicted V̇O2peak . Dashed lines represent the limits of
agreement (mean difference ±1.96 standard deviation). CPET, cardiopulmonary exercise testing; DASI, Duke Activity Status Index. A line of best fit is presented for
the Bruce treadmill test as proportional bias was detected.
12.5 ± 5.7 mL.kg−1.min−1, p = 0.751; n = 12). Bland-Altman
plots showing the level of agreement between measured and
predicted changes in the V̇O2peak values are shown in Figure 2.
A total of 50% of differences in changes in V̇O2peak values fell




The baseline V̇O2peak values demonstrated by the submaximal
step tests are shown in Table 3. Significant positive correlations
between the V̇O2peak values measured by CPET and those
predicted by the step tests were observed (r = 0.693, p < 0.001).
The step tests significantly overestimated V̇O2peak values when
compared to CPET (30.4 ± 5.6 vs. 26.3 ± 5.6 mL.kg−1.min−1,
p < 0.001, n = 34); the mean bias and 95% limits of agreement
was 4.1 mL.kg−1.min−1 (12.7,−4.5).
Follow-Up
The follow-up and changes in V̇O2peak values demonstrated
by the submaximal step tests are shown in Table 3. No
significant correlations between the change in V̇O2peak values
measured by CPET and those predicted by the step tests were
observed (r = 0.127, p = 0.513). No significant differences in
the change in V̇O2peak values measured by CPET and those
predicted by the step tests were observed (13.3 ± 5.5 vs.
11.9 ± 5.0 mL.kg−1.min−1, p = 0.300; n = 29). Bland-Altman
plots showing the level of agreement between measured and
predicted changes in the V̇O2peak values are shown in Figure 2.
A total of 38% of differences in changes in V̇O2peak values fell
within ± 1.75 mL.kg−1.min−1 (0.5 METs) of the mean bias
for the step tests.
Duke Activity Status Index
Baseline
The baseline V̇O2peak values demonstrated by the DASI are
shown in Table 3. Significant positive correlations between the
V̇O2peak values measured by CPET and those predicted by
the DASI were observed (r = 0.379, p = 0.008). The DASI
significantly overestimated V̇O2peak values when compared to
CPET (29.5 ± 5.2 vs. 25.8 ± 6.4 mL.kg−1.min−1, p < 0.001,
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n = 48); the mean bias and 95% limits of agreement was
3.6 mL.kg−1.min−1 (16.4,−9.2).
Follow-Up
The follow-up and changes in V̇O2peak values demonstrated
by the DASI are shown in Table 3. No significant correlations
between the change in V̇O2peak values measured by CPET
and those predicted by the DASI were observed (r = 0.085,
p = 0.587). No significant differences in the change in V̇O2peak
values measured by CPET and those predicted by the DASI were
observed (13.3 ± 5.4 vs. 12.3 ± 4.2 mL.kg−1.min−1, p = 0.307;
n = 43). Bland-Altman plots showing the level of agreement
between measured and predicted changes in the V̇O2peak values
are shown in Figure 2. A total of 58% of differences in changes in
V̇O2peak values fell within ± 1.75 mL.kg−1.min−1 (0.5 METs) of
the mean bias for the DASI.
Adverse Events
One participant was withdrawn from the study due to hemoptysis
(unidentified source) during the CR phase. This adverse event
was deemed serious, unexpected and unrelated to the study.
No adverse events occurred during the baseline or follow-up
CPET; reasons for test termination were expected and included:
fatigue, shortness of breath, chest pain (possible angina), leg
pain, dizziness, light-headedness, and lack of motivation. No
severe adverse events occurred during the baseline or follow-up
submaximal exercise tests. The mild and moderate symptoms
experienced during these exercise tests are summarized
in Table 4.
DISCUSSION
This study is the first, to our knowledge, to assess changes
in V̇O2peak following CR as predicted by three submaximal
exercise tests (i.e., treadmill, cycle and step) and a self-
reported activity status questionnaire (i.e., DASI) in comparison
with gold-standard CPET. In this pre-post experimental study,
we observed that most patients successfully completed the
step tests (baseline: 68%; follow-up: 80%), while few patients
successfully completed the cycle tests (baseline: 38%; follow-
up: 46%). Significant improvements from baseline to follow-up
in V̇O2peak were observed with CPET (3.6 mL.kg−1.min−1)
and predicted by the DASI (2.3 mL.kg−1.min−1), yet none
of the submaximal exercise tests. Bland-Altman plots revealed
significant proportional bias between the change in V̇O2peak
values measured by CPET and those predicted by the treadmill
test. No significant differences between the change in V̇O2peak
values measured by CPET and those predicted by the cycle
and step tests or DASI were observed; the mean bias and
limits of agreement were 1.0 mL.kg−1.min−1 (21.3, −19.3),
1.4 mL.kg−1.min−1 (15.0,−12.3) and 1.0 mL.kg−1.min−1 (13.8,
−11.8), respectively. Given the greater number of successful
tests, no serious adverse events and acceptable group-level mean
bias, the Chester step test appears to be a safe and valid
method for assessing mean, not individual-level changes in
V̇O2peak among patients with CVD in a CR program when
compared to gold-standard CPET. The DASI also appears to be a
practical, cost-effective and valid method for assessing mean, not
individual-level changes in V̇O2peak among patients with CVD
in a CR program.
Modified Bruce Treadmill Tests
We used the well-known ACSM walking equation to predict
V̇O2peak at baseline and follow-up using the final speeds and
grades obtained from the treadmill tests (American College of
Sports Medicine, 2017). Proportional bias was observed between
the change in V̇O2peak values measured by CPET and those
predicted by the treadmill test, such that there was greater
disagreement between the measured and predicted tests with
greater V̇O2peak values. Our data, therefore, indicate that the
treadmill test is not a valid tool for assessing changes in
V̇O2peak in patients with CVD completing a CR program.
Potential sources of error contributing to the proportional bias
may have included: the curvilinear relationship between oxygen
consumption, HR and workload at near-maximal effort (the
treadmill test assumes a linear relationship between HR and
workload); (Looney et al., 2019) and, the placing of their hands
on the treadmill rails for balance by several participants, during
their last or second last stage. The purpose of this study was to
assess a priori changes in V̇O2peak following CR as predicted by
the submaximal modified Bruce treadmill test (using the ACSM
walking equation) when compared to CPET. Future studies
could explore the validity of all available equations developed
for submaximal treadmill tests in those with CVD in predicting
changes in V̇O2peak following CR against gold-standard CPET.
Astrand-Ryhming Cycle Ergometer Tests
Very few participants successfully completed the cycle tests
as they were not able to continuously cycle for 6 min at a
sufficient workload (likely due to poor muscle strength and
endurance) to produce exercise HRs within the range of 120–
170 bpm (the HR range required to predict V̇O2peak from
the Astrand-Ryhming nomogram). More participants (46 vs.
38%) successfully completed the follow-up than baseline cycle
tests; these improvements may reflect the use of CR exercise
modalities which included cycling. As most (67%) participants
were taking β-blockers, it is likely that these HR blunting
medications prevented participants from achieving exercise HRs
on the nomogram. There is a need to develop a valid nomogram
or prediction equation to evaluate changes in V̇O2peak values
using the Astrand-Ryhming cycle test in patients with CVD who
frequently take HR blunting medications; this is beyond the scope
of this validation study and would require a larger sample size.
Chester Step Tests
The mean bias in changes in V̇O2peak was 1.4 mL.kg−1.min−1
(i.e., 0.4 METs) for the step test; there were no significant
differences between CPET and the step test. A modest increase of
1.75 to 3.5 mL.kg−1.min−1 (i.e., 0.5 to 1 METs) following CR is
considered clinically important (Grace et al., 2016), particularly
because an increase of this magnitude is strongly associated
with lower morbidity and mortality (Myers et al., 2002). The
step test, thus, appears to be appropriate for estimating mean
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TABLE 4 | Symptoms (moderate and mild) experienced during submaximal exercise tests.
Baseline Follow-up
Treadmill Cycle ergometer Step Treadmill Cycle ergometer Step
Moderate
Tightness in chest 1 – – – – –
Mild
Leg tightness/pain (hip, groin, thighs, quads, knees, calves) 8 4 6 6 3 3
Dizziness 1 1 1 – – 1
Lightheaded – – – 1 – –
Burning in chest – – 1 – – –
Shortness of breath – – 1 2 – –
Foot cramping – – 1 – – 1
Heart palpitations – – 1 – – –
Heart burn – – 1 – – –
Soreness at vein graft site – – 1 – – –
Edema in calves – – – 1 – –
Sciatic pain – – – 1 – –
TOTAL n (%) 10 (20) 5 (10) 13 (27) 11 (24) 3 (7) 5 (11)
changes in V̇O2peak following CR as the observed mean bias was
less than 1.75 mL.kg−1.min−1. However, caution is warranted
in using the step test to estimate changes in V̇O2peak following
CR on an individual-level given only 38% of the changes in
V̇O2peak values fell within ± 1.75 mL.kg−1.min−1 (0.5 METs)
of the mean bias for the step test, and we observed wide
limits of agreement (15, −12 mL.kg−1.min−1). Our findings
are consistent with classic studies showing that individual
predictions of V̇O2peak using progressive stepping tests are liable
to considerable error (Fitchett, 1985). Potential sources of error
contributing to the wide limits of agreement may have included:
the curvilinear relationship between oxygen consumption, HR
and workload at near-maximal effort (the step test assumes
a linear relationship between HR and workload); and, the
participants’ inability to maintain the correct stepping tempo
and technique, affecting mechanical efficiency (Bennett et al.,
2016). From our experience, participants found this exercise test
modality the most challenging, particularly for those fearful of
falling or who experienced difficulties with foot coordination. To
reduce error, we used: a statistical line of best fit to remove the
potential variability in drawing a visual line of best fit; measured
peak HR from CPET (Buckley et al., 2004); and, Polar HR
monitoring instead of manual HR recordings.
Duke Activity Status Index
The mean bias in changes in V̇O2peak was 1.0 mL.kg−1.min−1
(i.e., 0.3 METs) for the DASI; there were no significant
differences between CPET and the DASI. As mentioned above,
a modest increase of 1.75 to 3.5 mL.kg−1.min−1 following CR is
considered clinically important (Grace et al., 2016). The DASI,
thus, appears to be appropriate for estimating mean changes
in V̇O2peak following CR as the observed mean bias was less
than 1.75 mL.kg−1.min−1. However, one must exercise caution
when using the DASI to estimate individual-level changes in
V̇O2peak following CR given the wide limits of agreement (13.8,
−11.8 mL.kg−1.min−1), and only 58% of the changes in V̇O2peak
values fell within± 1.75 mL.kg−1.min−1 (0.5 METs) of the mean
bias for the DASI. Potential sources of error contributing to
the wide limits of agreement may have included: our measured
V̇O2peak values were obtained from CPET on a treadmill, while
the DASI was validated against CPET on a cycle ergometer
(Hlatky et al., 1989); V̇O2peak values obtained from treadmill
exercise may be up to 10% higher (Hermansen and Saltin,
1969). Further, several participants found the DASI questions
challenging to answer, particularly those who had not tried
an activity due to lack of interest (e.g., women who were not
interested in vigorous sports such as singles tennis), or other
scenarios (e.g., seasonal activities not performed during the
time of year participants completed the questionnaire, activities
participants had been advised not to engage in by their physician).
Safety
We meticulously tracked all mild, moderate and severe symptoms
and adverse events throughout this study. The greatest and fewest
number of symptoms (i.e., tightness in chest, leg tightness/pain,
dizziness, lightheaded, foot cramping, heart palpitations and
burning, edema, sciatic pain) occurred during the treadmill (20–
24%) and cycle (7–10%) testing, respectively. Given the mild
to moderate nature of these symptoms, which are expected
with exercise testing in patients with CVD, our findings suggest
that submaximal exercise testing does not pose any greater
risk than peak CPET. The risk of peak exercise testing is
low, with approximately 6 cardiovascular events per 10,000
tests (0.06%) occurring at >85% peak HR (American College
of Sports Medicine, 2017). In other studies examining the
use of submaximal exercise tests in predicting V̇O2peak when
compared to CPET at a single time point in patients with
CVD, potential adverse events were neither reported nor
discussed (Milani et al., 1996, 1998; Hautala et al., 2013;
Papini et al., 2017).
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Strengths and Limitations
Our study has several strengths. It is the first study to assess
changes in V̇O2peak following CR as predicted by submaximal
exercise tests of varying modalities and a self-reported activity
status questionnaire in comparison with gold-standard CPET.
This is particularly important as CPET is often impractical
due to the costs, time, expertise and technological resources
required. Consequently, CPET is underutilized in many CR
settings. Second, the submaximal exercise tests were performed
in a random order before the participants’ first three and last
three consecutive CR classes to reduce order bias. Third, we
meticulously tracked medications to ensure similar medications
were taken before CPET and submaximal exercise testing to
account for the HR blunting effects of β-blockers (Reed and Pipe,
2016). Finally, all peak and submaximal tests were performed
on the same treadmill, cycle or step. We used actual peak
HR from the CPET for submaximal test termination criteria
(i.e., 85% HRpeak for the treadmill and step tests) as age-
predicted HRpeak have been shown to overestimate actual
HRpeak and there’s no gold-standard prediction equation to
use; further, we used actual peak HR from the CPET to first
evaluate these submaximal tests under “best case” conditions (i.e.,
when both CPET and submaximal exercise tests are available)
(Buckley et al., 2004).
Several limitations should be mentioned. First, the
generalizability of our findings to females with CVD participating
in CR is limited as 77% of our sample was male – typical of
the under-representation of females enrolling in and adhering
to CR (Samayoa et al., 2014; Oosenbrug et al., 2016). Future
studies examining sex differences in V̇O2peak values predicted by
submaximal exercise tests of varying modalities in comparison
to CPET are needed as previous studies have reported different
mean bias values for apparently healthy females when compared
to males for the Chester step test (Sykes and Roberts, 2004).
Second, few participants successfully completed the cycle tests
(baseline: 38%; follow-up: 46%) which limited our power to
predict changes in V̇O2peak when compared to CPET. The
motivation required to complete a 6-min single-stage cycle test
may have been limiting when compared to 2–3 min multi-
stage treadmill and step tests, thus negatively impacting the
success rates of the cycle tests. Third, successful step tests were
defined as a participant having completed at least two stages
(to extrapolate V̇O2peak using the line of best fit function)
and reaching 85% of HRpeak upon completion of the final
stage. It is reasonable to assume that including a minimum of
two compared to three stages for a line of best fit calculation
may contribute to increased variance. However, this was not
observed in the current study (data not presented) likely due
to the few number of participants (n = 3) who would have
been removed from such analyses. Fourth, all participants
were recruited from a single tertiary-care cardiovascular health
center; future research would benefit from a multi-center trial
evaluating changes in V̇O2peak following CR as predicted by
submaximal exercise tests of varying modalities and the DASI
when compared to CPET. Finally and importantly, this study was
not powered to determine safety of submaximal exercise testing
in CR settings; future, larger, multi-center trials are needed for
such an evaluation.
CONCLUSION
The challenge in most rehabilitation settings is to induce
and maintain subtle but sustained changes in regular patterns
of physical activity – within a population that has typically
been inactive. Thus, there is a need for simple, inexpensive
approaches to both the evaluation of exercise capacity and
the provision of guidance regarding physical activity in
rehabilitation programs (Reed and Pipe, 2016). In situations
where CPET is not safe, practical or feasible (as is the case
for many CR programs), we conclude that the Chester step
tests and DASI appear to be a valid and safe submaximal
tools for predicting mean, not individual-level changes in
V̇O2peak following CR. Such testing may be appropriate when
only an estimate of V̇O2peak is required, as is typical for a
substantial number of CR settings, but not when an exact
measure is needed.
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